NanoViricides Inc. (NNVC)

[leifsmith]

Dr. Eugene Seymour - background - SEC filing, 2007

Eugene Seymour, MD, MPH, age 65, has been Chief Executive Officer (CEO) and a director of the Registrant since June 1, 2005. From 1996 until May 2005 he has been a private investor and has held no corporate positions. During this period he formed a non-profit foundation which funded both testing and training programs for health workers in Asia and Africa. He was a consultant to the UN Global Program on AIDS and was sent to several countries, (Lithuania, Latvia, Estonia and Russia) to interact with local physicians and assist them in setting up testing programs. Dr. Seymour obtained a Master's degree in the Epidemiology of Infectious Diseases at UCLA in addition to his medical degree. He began clinical practice in Internal Medicine and joined the UCLA Medical School faculty. Dr. Seymour served in the Medical Corps of US Army Reserve during the Vietnam era and attained the rank of Major. In 1986, he was requested by the US government to establish a testing laboratory and run a large-scale surveillance program for HIV prevalence in the Hispanic population in Los Angeles. His laboratory ended up testing over 50,000 people. In 1989, Dr. Seymour founded StatSure Diagnostic Systems, Inc. (SDS) (formerly Saliva Diagnostic Systems, Inc.), developed the rapid HIV antibody blood test (Hema-Strip) and took the company public in 1993 as CEO and President. Dr. Seymour holds 8 issued patents.

http://www.sec.gov/Archives/edgar/data/1379006/000114036107010671/form8k.htm

http://www.who.int/diagnostics_laboratory/documents/guidance/hemastrip.pdf